Latest News about ABBV
Recent news which mentions ABBV
AbbVie's Strategic Move: ImmunoGen Acquisition Triggers Golden Cross, Yet Valuation Caution Remains
January 11, 2024
From Benzinga
Aesthetics Market Resilience: AbbVie Asserts Widely Used Botox Dominance Amidst Rising Competition
January 11, 2024
From Benzinga
From Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
January 10, 2024
From Benzinga
From Benzinga
3 Simple Tricks That Every Investor Should Use (but Most Don't)
January 09, 2024
From Motley Fool
Cramer Says This Major Healthcare Stock Is 'Ridiculously Cheap And Doing So Many Great Things'
January 08, 2024
From Benzinga
5 Biotech Stocks That Should Be On Investors' Radar As JPMorgan Healthcare Conference Gets Underway Monday
January 08, 2024
From Benzinga
From Motley Fool
Is AbbVie Stock a Buy Now?
January 07, 2024
From Motley Fool
24 Top Dividend Stocks to Buy and Hold in 2024
January 07, 2024
From Motley Fool
3 Magnificent High-Yield Dividend Stocks to Buy in 2024
January 06, 2024
From Motley Fool
1 Concerning Trend for AbbVie Investors to Keep an Eye On
January 03, 2024
Tickers
ABBV
From Motley Fool
3 Biotech Stocks Set for Breakthroughs in 2024
January 02, 2024
From InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
January 02, 2024
From Benzinga
2 Biotech Stocks You Can Buy and Hold for the Next Decade
January 02, 2024
From Motley Fool
3 Top Dividend Growth Stocks to Buy in 2024
January 02, 2024
From Motley Fool
The 3 Hottest Dividend Stocks to Watch in 2024
January 01, 2024
From InvestorPlace
3 Top ETFs I'm Planning to Buy Hand Over Fist in 2024, Despite All the Cheap Stocks on My Radar
January 01, 2024
From Motley Fool
Got $1,500? You Can Confidently Add These 3 Stocks to Your Portfolio
December 31, 2023
From Motley Fool
4 Incredible Dividend Stocks Yielding 4%-Plus to Buy in 2024
December 31, 2023
From Motley Fool
Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024
December 29, 2023
From Benzinga
AbbVie's Recent ImmunoGen Acquisition Looks Brilliant: Here's Why
December 26, 2023
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.